Off-label information dissemination for serious illnesses will be studied by AMA board.
Executive Summary
OFF-LABEL USE INFORMATION DISSEMINATION FOR CATASTROPHIC ILLNESS will be studied by the American Medical Association under a resolution adopted by the AMA House of Delegates June 25 at its annual meeting in Chicago. The policy directs the AMA Board of Trustees to prepare "an in-depth study of the scientific, legal and regulatory aspects of this complicated issue," according to materials presented by the Reference Committee on Science & Technology, which recommended the action to the full House.